CHINA CHENGTONG (00217) issued its 2024 annual performance report, with net profit attributable to shareholders of HK$38.633 million, a year-on-year decrease of 43.2%.
China Chengtong Development Group (00217) released its annual performance for the year ending December 31, 2024, with a revenue of 5...
CHINA CHENGTONG (00217) released its annual performance for the year ending December 31, 2024, with a revenue of 553 million Hong Kong dollars, a decrease of 25.3% compared to the previous year. The net profit attributable to owners of the company was 38.633 million Hong Kong dollars, a decrease of 43.2% year-on-year. Basic earnings per share were 0.65 Hong Kong cents, with a proposed final dividend of 0.20 Hong Kong cents per share.
The decrease in revenue during the period was attributed to the group adopting a more cautious strategy in developing new leasing business due to uncertainties in the external economic environment.
Related Articles

Huagong Tech's subsidiary plans to participate in setting up Ruiyuan Fund II with an amount not exceeding 76.5 million yuan.

KWAN YONG (09998) announces a profit, with expected annual net profit attributable to shareholders of about 12.9 million Singapore dollars, a significant increase compared to the same period last year.

Hainan Huluwa Pharmaceutical Group (605199.SH) has been granted approval to conduct clinical trials for pediatric pulmonary heat cough and asthma granules.
Huagong Tech's subsidiary plans to participate in setting up Ruiyuan Fund II with an amount not exceeding 76.5 million yuan.

KWAN YONG (09998) announces a profit, with expected annual net profit attributable to shareholders of about 12.9 million Singapore dollars, a significant increase compared to the same period last year.

Hainan Huluwa Pharmaceutical Group (605199.SH) has been granted approval to conduct clinical trials for pediatric pulmonary heat cough and asthma granules.

RECOMMEND

Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025

Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025

Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025